<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.3 20210610//EN" "JATS-archivearticle1-3.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="case-report" dtd-version="1.3" xml:lang="en">
  <front>
    <journal-meta>
      <journal-id journal-id-type="publisher-id">JPSIM</journal-id>
      <journal-title-group>
        <journal-title>Journal of Pakistan Society of Internal Medicine</journal-title>
        <abbrev-title>J Pak Soc Intern Med</abbrev-title>
      </journal-title-group>
      <issn publication-format="print">2709-8729</issn>
      <issn publication-format="electronic">2710-0804</issn>
      <publisher>
        <publisher-name>Pakistan Society of Internal Medicine</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="doi">10.70302/jpsim.v3i1.2212</article-id>
      <article-id pub-id-type="publisher-id">jpsim.v3i1.2212</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Bradycardia with Remdesivir Therapy for Covid-19 Pneumonitis</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author" corresp="yes">
          <name>
            <surname>Humayun</surname>
            <given-names>Malik Asif</given-names>
          </name>
          <email>doctormalikasif@gmail.com</email>
          <xref ref-type="aff" rid="aff1"/>
          <xref ref-type="corresp" rid="cor1">*</xref>
        </contrib>
      </contrib-group>
      <aff id="aff1">
        <institution>Consultant Physician, UK.</institution>
      </aff>
      <author-notes>
        <corresp id="cor1">*Correspondence: Malik Asif Humayun (doctormalikasif@gmail.com)</corresp>
      </author-notes>
      <pub-date date-type="pub" publication-format="electronic" iso-8601-date="2022-03-15">
        <day>15</day>
        <month>03</month>
        <year>2022</year>
      </pub-date>
      <pub-date date-type="collection" publication-format="electronic">
        <year>2022</year>
      </pub-date>
      <volume>3</volume>
      <issue>1</issue>
      <fpage>58</fpage>
      <lpage>62</lpage>
      <history>
        <date date-type="received" iso-8601-date="2021-11-11">
          <day>11</day>
          <month>11</month>
          <year>2021</year>
        </date>
        <date date-type="accepted" iso-8601-date="2022-01-03">
          <day>03</day>
          <month>01</month>
          <year>2022</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Copyright © 2022 The Author(s)</copyright-statement>
        <copyright-year>2022</copyright-year>
        <copyright-holder>The Author(s)</copyright-holder>
        <ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/>
        <license license-type="open-access" xlink:href="https://creativecommons.org/licenses/by/4.0/">
          <ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
          <license-p>This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
        </license>
      </permissions>
      <self-uri xlink:href="https://psimj.com/article/jpsim.v3i1.2212" content-type="text/html"/>
      <self-uri xlink:href="https://psimj.com/article/jpsim.v3i1.2212.pdf" content-type="application/pdf"/>
    </article-meta>
  </front>
  <!-- <body> omitted: no manuscript (.docx) on file -->
  <back>
    <ref-list>
      <title>References</title>
      <ref id="ref1">
        <label>1</label>
        <mixed-citation>Munther K Homoud, MD, Jonathan Piccini, Susan B Yeon. Sinus bradycardia. https://www.uptodate.com/contents/sinusbradycardia?search=sinus%20bradycardia&amp;source=search_result&amp;selectedTitle=1~150&amp;usage_type=default&amp;display_rank=1#H14 [Accessed 17th February 2021].</mixed-citation>
      </ref>
      <ref id="ref2">
        <label>2</label>
        <mixed-citation>Adam She1wat; Jeffrey MmTay; Debra Birnkrant; and John Farley. Cross-Discipline Team Leader, Division Director, and ODE Summary Review. FDA. Center for drug evaluation and research application number: 214787orig1s000 summary review. Gilead Sciences, Inc. August 7, 2020.</mixed-citation>
      </ref>
      <ref id="ref3">
        <label>3</label>
        <mixed-citation>Wang Y, Zhang D, Du G, Du R, Zhao J, Jin Y, et al. Remdesivir in adults with severe COVID-19: a randomized, double-blind, placebo-controlled, multicenter trial. Lancet. 2020 May 16;395(10236):1569–78. April 29, 2020 https://doi.org/10.1016/ S0140-6736(20)31022-9</mixed-citation>
      </ref>
      <ref id="ref4">
        <label>4</label>
        <mixed-citation>Gupta AK, Parker BM, Priyadarshi V, Parker J. Cardiac Adverse Events with Remdesivir in COVID-19 Infection. Cureus. 2020 Oct 24; <pub-id pub-id-type="doi">10.7759/cureus.11132</pub-id></mixed-citation>
      </ref>
      <ref id="ref5">
        <label>5</label>
        <mixed-citation>Barkas F, Styla CP, Bechlioulis A, Milionis H, Liberopoulos E. Sinus bradycardia associated with remdesivir treatment in covid-19: A case report and literature review. J Cardiovasc Dev Dis. 2021 Feb 1;8(2):1–5.</mixed-citation>
      </ref>
      <ref id="ref6">
        <label>6</label>
        <mixed-citation>Gubitosa JC, Kakar P, Gerula C, Nossa H, Finkel D, Wong K, et al. Marked Sinus Bradycardia Associated With Remdesivir in COVID-19: A Case and Literature Review. JACC Case Reports. 2020 Nov 18;2(14):2260–4.</mixed-citation>
      </ref>
      <ref id="ref7">
        <label>7</label>
        <mixed-citation>Mendez-Echevarria A,Kinga-Amalia S .B&amp; Calvo C, Severe sinus bradycardia associated with remdesivir in a childwith severe SARS-COV-2 infection—reply. European Journal of Pediatrics. Published online 19th January 021.<pub-id pub-id-type="doi">10.1007/s00431-021-03952-0.[Accessed</pub-id> 14th March 2021]</mixed-citation>
      </ref>
      <ref id="ref8">
        <label>8</label>
        <mixed-citation>Ahmed M, Yousif A, Hamad G.O, El-Raheem A, Salih D, Mohamed I. Use of Remdesivir in The Treatment of COVID-19 Infection Among Sudanese Patients-Case Series. Available from: <pub-id pub-id-type="doi">10.21203/rs.3.rs-153556/v1</pub-id></mixed-citation>
      </ref>
      <ref id="ref9">
        <label>9</label>
        <mixed-citation>Mulangu S, Dodd LE, Davey RT, Tshiani Mbaya O, Proschan M, Mukadi D, et al. A Randomized, Controlled Trial of Ebola Virus Disease Therapeutics. N Engl J Med. 2019 Dec 12; 381(24):2293–303.</mixed-citation>
      </ref>
      <ref id="ref10">
        <label>10</label>
        <mixed-citation>Kuck KH. Arrhythmias and sudden cardiac death in the COVID-19 pandemic. Vol. 45, Herz. Springer Medizin; 2020. p. 325–6.</mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>
